We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPanthera Res. Regulatory News (PAT)

Share Price Information for Panthera Res. (PAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 6.00
Ask: 7.00
Change: 0.10 (1.54%)
Spread: 1.00 (16.667%)
Open: 6.50
High: 6.60
Low: 6.60
Prev. Close: 6.50
PAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Equity Financing

6 Dec 2023 10:22

RNS Number : 8829V
Panthera Resources PLC
06 December 2023
 

THIS ANNOUNCEMENT, INCLUDING THE APPENDIX AND THE INFORMATION IN IT, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, NEW ZEALAND, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("EUWA")) ("UK MAR"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF INSIDE INFORMATION (AS DEFINED UNDER UK MAR). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION, WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

6 December 2023

 

Panthera Resources Plc

("Panthera" or "the Company")

 

Equity Financing

 

Panthera Resources plc (AIM: PAT), the gold exploration and development company with assets in India and West Africa, is pleased to announce that it has arranged an equity capital fundraise with new and existing investors for approximately £785,000 (before expenses) by way of a placing and subscription (the "Placing" and the "Subscription" respectively) (together the "Equity Financing") of a total of 15,700,000 ordinary shares of 1 pence each in the Company (the "Ordinary Shares") at a price of 5 pence per new Ordinary Share (the "Placing Price"). Novum Securities Limited ("Novum") are acting as broker in connection with the Placing.

 

It is intended that the proceeds of the Equity Financing will be used towards the Company's activities in India and West Africa and meeting the Company's working capital commitments.

 

Details of the Equity Financing

 

The Equity Financing comprises a Placing of 5,200,000 new Ordinary Shares (the "Placing Shares") and a Subscription of 10,500,000 new Ordinary Shares (the "Subscription Shares") at the Placing Price. The Equity Financing has been conducted as a private placement and subscription under the Company's existing allotment and pre-emption disapplication authorities and participation has not been made available to members of the public. The Placing Shares and the Subscription Shares will rank pari passu with the existing Ordinary Shares in the Company.

 

The Company has received binding subscription commitments of 7,500,000 shares and indicative subscription commitments of 3,000,000 from subscribers to the equity capital raising to subscribe for new Ordinary Shares at the Placing Price respectively. 

 

Novum has each entered a placing agreement ('Placing Agreement') with the Company under which they have, on the terms and subject to the conditions set out therein (including Admission, as defined below), undertaken to use its reasonable endeavours to procure subscribers for the Placing Shares at the Placing Price. The Placing Agreement contains certain warranties and indemnities from the Company in favour of Novum. In addition, the Company has agreed to pay Allenby Capital Limited ("Allenby Capital") a fundraise commission in connection with certain investors introduced by Allenby Capital to the Subscription.

 

The Subscription is subject to terms and conditions agreed between the Company and each of the subscribers for the Subscription Shares and is conditional, inter alia, on Admission (as defined below). The Subscription is conditional, inter alia, upon the completion of the Placing. Neither the Placing nor the Subscription are being underwritten by Allenby Capital, Novum or any other person.

 

In addition, pursuant to the Placing Agreement with Novum and as a result of certain funds separately introduced by Allenby Capital to the Subscription, the Company has agreed to issue 312,000 options and 180,000 options to Novum and Allenby Capital respectively, exercisable at a price of 5 pence on or before two years from the date of Admission (as defined below) (together the "Option") with each Option entitling the holder to acquire one new Ordinary Share upon exercise of the Option.

 

Shares in Lieu

 

The Company has agreed to issue 780,000 new Ordinary Shares at 5 pence per new Ordinary Share to certain advisors to settle fees, including Novum in relation to their ongoing appointment as joint broker (together the "Fee Shares").

 

Admission and total voting rights

 

Application will be made to London Stock Exchange plc for the Placing Shares, the Subscription Shares and the Fee Shares to be admitted to trading on AIM ("Admission"). It is currently anticipated that Admission will become effective and that dealings in the Placing Shares, the Subscription Shares and the Fee Shares will commence on AIM at 8.00 a.m. on or around 14 December 2023.

 

Upon Admission of the 16,480,000 new Ordinary Shares, the Company's issued ordinary share capital will consist of 170,989,083 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 170,989,083. With effect from Admission, this figure may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Contacts

 

Panthera Resources PLC

Mark Bolton (Managing Director) +61 411 220 942

contact@pantheraresources.com

 

Allenby Capital Limited (Nominated Adviser & Joint Broker) +44 (0) 20 3328 5656

John Depasquale / Vivek Bhardwaj (Corporate Finance)

Guy McDougall / Kelly Gardiner (Sales & Corporate Broking)

 

Novum Securities Limited (Joint Broker) +44 (0) 20 7399 9400

Colin Rowbury

 

Financial Public Relations

Zak Mir +44 (0) 786 752 7659

 

Subscribe for Regular Updates

 

Follow the Company on Twitter at: @PantheraPLC

 

For more information and to subscribe to updates visit: pantheraresources.com

 

Forward-looking Statements

This news release contains forward-looking statements that are based on the Company's current expectations and estimates. Forward-looking statements are frequently characterised by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "suggest", "indicate" and other similar words or statements that certain events or conditions "may" or "will" occur. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Such factors include, among others: the actual results of current exploration activities; conclusions of economic evaluations; changes in project parameters as plans continue to be refined; possible variations in ore grade or recovery rates; accidents, labour disputes, and other risks of the mining industry; delays in obtaining governmental approvals or financing; and fluctuations in metal prices. There may be other factors that cause actions, events, or results not to be as anticipated, estimated, or intended. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events, or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly, undue reliance should not be put on such statements due to the inherent uncertainty therein.

 

Notice to Distributors

 

Solely for the purposes of the product governance requirement contained in Chapter 3 of the FCA Product Intervention and Product Governance Sourcebook (together, the "UK Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the UK Product Governance Requirements) may otherwise have with respect thereto, the Placing Shares have been subject to a product approval process, which has determined that the Placing Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, as defined under the FCA Handbook Conduct of Business Sourcebook, and (ii) eligible for distribution through all permitted distribution channels (the "Target Market Assessment").

 

Notwithstanding the Target Market Assessment, distributors should note that: the price of the Placing Shares may decline and investors could lose all or part of their investment; the Placing Shares offer no guaranteed income and no capital protection; and an investment in the Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Placing Shares. Furthermore, it is noted that, notwithstanding the Target Market Assessment, Allenby Capital Limited will only procure investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of the FCA Handbook Conduct of Business Sourcebook COBS 9A and 10A respectively; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Placing Shares.

 

Each distributor is responsible for undertaking its own target market assessment in respect of the Placing Shares and determining appropriate distribution channels.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

**ENDS**

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBQLFBXLLLFBB
Date   Source Headline
2nd Apr 20247:09 amRNSTotal Voting Rights
2nd Apr 20247:09 amRNSUpdate On Dispute With India
4th Mar 20247:00 amRNSShares in Lieu
9th Feb 20247:01 amRNSExercise of Wuo Land 2 Option
6th Feb 20249:22 amRNSKalaka and Bido Project Update
2nd Jan 20247:00 amRNSIssue of Notice of Dispute with India
29th Dec 20231:00 pmRNSTotal Voting Rights
29th Dec 20237:00 amRNSHalf-year Report
18th Dec 20237:38 amRNSEquity Financing Update
6th Dec 202310:22 amRNSEquity Financing
29th Nov 202310:30 amRNSResult of Meeting
9th Nov 20237:00 amRNSBhukia Update
31st Oct 20237:00 amRNSNotice of AGM
9th Oct 20237:00 amRNSKalaka Project Drilling Assay Results
27th Sep 20238:34 amRNSRajasthan High Court Decision
25th Aug 20237:00 amRNSFunding Confirmation Notice: US$13.6 million
22nd Aug 20237:13 amRNSArbitration Financing Update
21st Aug 202310:46 amRNSCompletion of Drilling at Kalaka
14th Aug 20237:00 amRNSArbitration Financing Update
31st Jul 20235:00 pmRNSTotal Voting Rights
31st Jul 20238:43 amRNSArbitration Financing Update
17th Jul 20238:07 amRNSArbitration Financing Update
11th Jul 20238:00 amRNSExecutive Service Agreement Variation
10th Jul 20237:00 amRNSKalaka Drilling Programme
4th Jul 20237:00 amRNSEquity Financing Update
3rd Jul 20237:00 amRNSArbitration Financing Update
28th Jun 202311:30 amRNSResult of Meeting
12th Jun 20237:00 amRNSNotice of GM
5th Jun 202312:28 pmRNSTotal Voting Rights
1st Jun 20237:00 amRNSArbitration Financing Update
25th May 20237:32 amRNSCascades Drilling Results
2nd May 20237:10 amRNSEquity Financing Update
2nd May 20237:00 amRNSOperations Update
19th Apr 20231:32 pmRNSEquity Issue Update
12th Apr 202310:13 amRNSDirector/PDMR Shareholding
29th Mar 20237:30 amRNSIssue of Equity
8th Mar 20234:35 pmRNSPrice Monitoring Extension
8th Mar 20232:05 pmRNSSecond Price Monitoring Extn
8th Mar 20232:00 pmRNSPrice Monitoring Extension
3rd Mar 20234:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSArbitration Funding for up to US$10.5 million
13th Feb 20237:00 amRNS10000m Drilling Programme Commenced at Cascades
23rd Dec 20229:14 amRNSHalf Year Report 30 September 2022
23rd Nov 202211:36 amRNSResult of AGM
12th Oct 20227:00 amRNSBido Exploration Update
10th Oct 20221:32 pmRNSEquity Financing Update
5th Oct 202212:17 pmRNSTotal Voting Rights
3rd Oct 20221:27 pmRNSEquity Financing
30th Sep 20222:08 pmRNSAnnual Financial Report 31 March 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.